Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resistant lovo colon cancer via mitochondrial dysfunction and activation of JNK and p38.

Chemotherapy causes unwanted side effects and chemoresistance, limiting its effectiveness. Therefore, phytochemicals are now used as alternative treatments. Thymoquinone (TQ) is used to treat different cancers, including colon cancer. The irinotecan-resistant (CPT-11-R) LoVo colon cancer cell line was previously constructed by stepwise CPT-11 challenges to untreated parental LoVo cells. TQ dose-dependently increased the total cell death index and activated apoptosis at 2 μM, which then diminished at increasing doses. The possibility of autophagic cell death was then investigated. TQ caused mitochondrial outer membrane permeability (MOMP) and activated autophagic cell death. JNK and p38 inhibitors (SP600125 and SB203580, respectively) reversed TQ autophagic cell death. TQ was also found to activate apoptosis before autophagy, and the direction of cell death was switched toward autophagic cell death at initiation of autophagosome formation. Therefore, TQ resulted in caspase-independent, autophagic cell death via MOMP and activation of JNK and p38 in CPT-11-R LoVo colon cancer cells.

[1]  F. Tsai,et al.  Resistance to irinotecan (CPT-11) activates epidermal growth factor receptor/nuclear factor kappa B and increases cellular metastasis and autophagy in LoVo colon cancer cells. , 2014, Cancer letters.

[2]  Takashi Takahashi,et al.  Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo , 2013, Fundamental & clinical pharmacology.

[3]  Brian J. Smith,et al.  RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients. , 2013, Genes & cancer.

[4]  Jing-Gung Chung,et al.  Anticancer potential of emodin , 2012, BioMedicine.

[5]  J. Marin,et al.  Genetic variants in genes involved in mechanisms of chemoresistance to anticancer drugs. , 2012, Current cancer drug targets.

[6]  E. White.  Deconvoluting the context-dependent role for autophagy in cancer , 2012, Nature Reviews Cancer.

[7]  A. Baldwin.  Regulation of cell death and autophagy by IKK and NF‐κB: critical mechanisms in immune function and cancer , 2012, Immunological reviews.

[8]  D. Green,et al.  Mitochondria and cell death: outer membrane permeabilization and beyond , 2010, Nature Reviews Molecular Cell Biology.

[9]  M. Hande,et al.  Thymoquinone Induces Telomere Shortening, DNA Damage and Apoptosis in Human Glioblastoma Cells , 2010, PloS one.

[10]  R. Shi,et al.  Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo , 2010, Journal of experimental & clinical cancer research : CR.

[11]  Lynette M. Smith,et al.  Effects of Thymoquinone in the Expression of Mucin 4 in Pancreatic Cancer Cells: Implications for the Development of Novel Cancer Therapies , 2010, Molecular Cancer Therapeutics.

[12]  R. Schneider-Stock,et al.  Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling , 2010, Apoptosis.

[13]  Sung-Hoon Kim,et al.  Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells , 2009, Molecular Cancer Therapeutics.

[14]  N. Mizushima,et al.  A receptor for eating mitochondria. , 2009, Developmental cell.

[15]  F. Khuri,et al.  Perspectives for cancer prevention with natural compounds. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Seon-Hee Oh,et al.  Dihydrocapsaicin (DHC), a saturated structural analog of capsaicin, induces autophagy in human cancer cells in a catalase-regulated manner , 2008, Autophagy.

[17]  Sung-Liang Yu,et al.  Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. , 2008, Cancer research.

[18]  Mingyao Liu,et al.  Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways , 2008, Molecular Cancer Therapeutics.

[19]  J. Milner,et al.  Diet, Autophagy, and Cancer: A Review , 2008, Cancer Epidemiology Biomarkers & Prevention.

[20]  K. Griffith,et al.  Resveratrol inhibits glucose metabolism in human ovarian cancer cells. , 2007, Gynecologic oncology.

[21]  Y. Pommier.  Topoisomerase I inhibitors: camptothecins and beyond , 2006, Nature Reviews Cancer.

[22]  Shivendra V. Singh,et al.  Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. , 2006, Cancer research.

[23]  G. Kroemer,et al.  The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death , 2005, Journal of Cell Science.

[24]  Y. Luqmani.  Mechanisms of Drug Resistance in Cancer Chemotherapy , 2005, Medical Principles and Practice.

[25]  P. Marks,et al.  Apoptotic and autophagic cell death induced by histone deacetylase inhibitors , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Y. Kaneda,et al.  Inhibition of inducible NF-kappaB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line. , 2003, Experimental cell research.

[27]  Kinzo Matsumoto,et al.  Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone, in mice. , 2000, European journal of pharmacology.

[28]  J. Cusack,et al.  NF- kappa B and chemoresistance: potentiation of cancer drugs via inhibition of NF- kappa B. , 1999, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[29]  O. Badary,et al.  Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. , 1998, Journal of experimental & clinical cancer research : CR.

[30]  B Drewinko,et al.  Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. , 1976, Cancer research.

[31]  Chi-Tang Ho,et al.  Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. , 2011, Molecular nutrition & food research.

[32]  D. Cunningham,et al.  Targeted drug therapies and cancer. , 2011, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[33]  B. Aggarwal,et al.  Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy , 2006 .

[34]  R. Schneider-Stock,et al.  Thymoquinone: a promising anti-cancer drug from natural sources. , 2006, The international journal of biochemistry & cell biology.